AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2015
May 12, 2015
35134_dirs_2015-05-12_c629accf-7618-4824-a35d-f2c735ab952e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2015-05-11
Reporting Person: Thompson Tommy G (Director, Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-11 | Common Stock | P | 3000 | $6.09 | Acquired | 661257 | Indirect |
| 2015-05-11 | Common Stock | P | 3000 | $6.09 | Acquired | 3555 | Direct |
Footnotes
F1: Owned by Thompson Family Investments, LLC
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16